Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal microbiome modulation refers to the intentional alteration of the composition, diversity, or activity of the microbial community within the gastrointestinal (GI) tract. This process aims to improve host health by influencing various physiological functions, including metabolism, immune regulation, and protection against pathogens. Strategies include dietary interventions, prebiotics, probiotics, antibiotics, post-biotics, and fecal microbiota transplantation.
Modulation of the gastrointestinal microbiome through dietary interventions, prebiotics, probiotics, antibiotics, post-biotics, or fecal microbiota transplantation to alter the composition, diversity, or activity of the microbial community within the gastrointestinal (GI) tract, aiming to improve host health.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal microbiome modulation.